Low molecular weight heparin use in cancer treatment
Wednesday, February 15, 2012 - 21:30
in Health & Medicine
Researchers suggest conclusive answers to key questions on the benefits of low molecular weight heparin (LMWH) for cancer patients remain elusive - despite promising results from large studies.